Nice digestion Today
Spy’s went into yesterday’s gap and held like a champ. We mentioned in the morning...
Read MoreJan 4, 2012
Spy’s went into yesterday’s gap and held like a champ. We mentioned in the morning...
Read MoreJan 4, 2012
On Tuesday, the US Bank NA, a unit of U.S. Bancorp (USB), filed a lawsuit against JPMorgan Chase...
Read MoreJan 4, 2012
China’s Premier Wen Jiabao has just warned that China’s economy is now facing...
Read MoreJan 4, 2012
In 2011, as in 2010, America was in a technical recovery but continued to suffer from disastrously...
Read MoreJan 4, 2012
Gloom, Boom and Doom editor Marc Faber says investors should hold off buying India’s stocks...
Read MoreJan 4, 2012
Coventry Health Care Inc. (CVH”>CVH) announced the closure of its acquisition of...
Read MoreJan 4, 2012
Twenty-two months of hysteria of an impending European financial collapse, starting with Greece in...
Read MoreJan 4, 2012
Ford Motor Co. (F) unveiled its new global compact sports utility vehicle (SUV) EcoSport at the...
Read MoreJan 4, 2012
In this corner, weighing in at 45 kilograms soaking wet … he’s all the rage in Paris,...
Read MoreJan 4, 2012
Yesterday, most stocks and commodities took off and rallied to the upside. The iPath Dow Jones-UBS...
Read MoreJan 4, 2012
Recently, Regeneron Pharmaceuticals, Inc. (REGN”>REGN) reached a non-exclusive license and...
Read MoreJan 4, 2012
Ameren Illinois, a subsidiary of Ameren Corporation (AEE”>AEE), has filed for the...
Read MoreJan 4, 2012
Forexpros – bsp;- Gold futures continued their advance on Wednesday on safe haven buying...
Read MoreJan 4, 2012
Osiris Therapeutics, Inc. (OSIR”>OSIR) recently provided an update on its stem cell therapy...
Read MoreJan 4, 2012
The commodity which enjoyed the biggest gain in price last year can be answered with a simple...
Read MoreJan 4, 2012
Canadian National (CNI) started the year with the consolidation of its corporate structure, namely...
Read MoreJan 4, 2012
The table below provides the top- and bottom-twenty ETFs sorted by 2011 Historic Volatility. Also...
Read MoreJan 4, 2012
As the curtain falls on the gift-giving season, the analysts are keeping a close watch on the...
Read MoreJan 4, 2012
By James Picerno of The Capital Speculator A new year has arrived and that can only mean one...
Read MoreJan 4, 2012
We are maintaining our Neutral stance on AstraZeneca (AZN) with a target price of $48.00....
Read MoreJoin our mailing list to receive the latest news and updates from our team.

